Furthermore, studies with the use of non-small cell lung cancer (NSCLC) cell lines have indicated that increased COX-2 activity might contribute to the stabilization of survivin in these cells [59,60]. The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.